thiazolyl blue has been researched along with enkephalin, ala(2)-mephe(4)-gly(5)- in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martin-Kleiner, I | 1 |
| Han, JS; He, Y; Jordan-Sciutto, KL; Wang, M; Wang, Y; Xie, WY; Yang, YR; Yin, DM; Zhang, Y | 1 |
2 other study(ies) available for thiazolyl blue and enkephalin, ala(2)-mephe(4)-gly(5)-
| Article | Year |
|---|---|
The effect of opioid agonists of delta-class DSLET, mu-class DAMGO, kappa-class U-69593 and an opioid antagonist, naloxone, on MTT activity of NALM-1 leukemic cells.
Topics: Benzeneacetamides; Cell Division; Cell Survival; Colorimetry; DNA Fragmentation; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine; Humans; Leukemia; Naloxone; Narcotic Antagonists; Pyrrolidines; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2002 |
Role of CDK5 in neuroprotection from serum deprivation by mu-opioid receptor agonist.
Topics: Animals; Blotting, Western; Cell Death; Cells, Cultured; Culture Media, Serum-Free; Cyclin-Dependent Kinase 5; Drug Interactions; Embryo, Mammalian; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Female; Gene Expression Regulation; Hippocampus; Humans; Mutagenesis; Naloxone; Neurons; Neuroprotective Agents; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Serum; Tetrazolium Salts; Thiazoles; Time Factors; Transfection | 2006 |